NEKTAR THERAPEUTICS shareholders Q3 2023

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.

NEKTAR THERAPEUTICS shareholders Q3 2023
NameSharesValueWeighting ↓
AQR Capital Management 3,666,264$2,183,6270.01%
Maltin Wealth Management, Inc. 13,000$7,7430.01%
ALGERT GLOBAL LLC 180,630$1080.01%
D. E. Shaw & Co., Inc. 6,123,024$3,646,8730.00%
PRIMECAP MANAGEMENT CO/CA/ 7,197,983$4,287,1190.00%
Renaissance Technologies 3,506,681$2,0890.00%
MARSHALL WACE, LLP 2,936,218$1,761,7320.00%
Hall Private Wealth Advisors 10,000$5,9560.00%
TWO SIGMA INVESTMENTS, LP 2,795,049$1,664,7310.00%
Point72 Asset Management, L.P. 1,520,578$905,6560.00%
Adero Partners, LLC 51,500$30,6730.00%
LIBERTY WEALTH MANAGEMENT LLC 19,000$110.00%
Hennion & Walsh Asset Management, Inc. 73,313$43,6650.00%
VERUS CAPITAL PARTNERS, LLC 38,808$23,1140.00%
BALYASNY ASSET MANAGEMENT L.P. 1,333,668$794,3330.00%
Connor, Clark & Lunn Investment Management Ltd. 491,975$293,0200.00%
OCCUDO QUANTITATIVE STRATEGIES LP 28,738$17,1160.00%
FRANKLIN STREET ADVISORS INC /NC 15,500$90.00%
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO 310,124$185,0000.00%
China Universal Asset Management Co., Ltd. 4,880$30.00%
External links

This page lists NEKTAR THERAPEUTICS's shareholders in Q3 2023. To view NEKTAR THERAPEUTICS's shareholder history, click here.